Mesothelioma Current Events | Mesothelioma News
|
|
|
Sort By:
Page Views | Date |
Early Promise Of Blood Marker To Detect Mesothelioma (p 1612)
Preliminary results of a study in this week's issue of THE LANCET suggest that a blood test could be used in the future to identify people with mesothelioma-the usually deadly malignant tumor of mesothelial tissue surrounding the lungs, often caused by exposure to asbestos. Bruce Robinson from Sir Charles Gairdner Hospital, Perth, Australia, and... view more... (2003-11-12)
Asbestos disease projections too low
Current predictions of the future incidence of asbestos-related disease have been substantially underestimated, according to new modelling to be presented in Melbourne today by an epidemiologist from The Australian National University. view more (2007-04-03)
UK faces asbestos epidemic
The United Kingdom is facing an epidemic of mesothelioma (a malignant tumour of the lung lining) among workers exposed to asbestos, warn senior doctors in this week's BMJ. There are now over 1800 mesothelioma deaths per year in Britain (more than one in 200 of all deaths in men and almost one in 1000 in women) and the number is still increasing.... view more... (2004-01-29)
New drugs boost for asbestos-related lung cancer sufferers
Clinical trials of a new anticancer drug combination carried out by researchers at Newcastle University show that it has potential to almost double the life expectancy of sufferers of Mesothelioma - a form of lung cancer which affects around 1,700 people in the UK every year - according to a report published in the Journal of Clinical Oncology.... view more... (2002-08-12)
New clinical trial for patients with asbestos-associated lung cancer
The Mesothelioma Center within the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian Hospital and Columbia University Medical Center is now recruiting patients for a clinical research study of a new targeted radiation and chemotherapy protocol for pleural mesothelioma, a cancer of the lung's lining that is almost always caused by... view more... (2008-06-26)
Elevated blood levels of a protein are linked to asbestos-induced cancers
Researchers at New York University School of Medicine and Wayne State University have found a molecule that reveals the early stages of pleural mesothelioma, a chest cancer caused by asbestos. view more (2005-10-13)
Chemo combination improves survival in asbestos-related cancer
People with mesothelioma — a form of cancer associated with asbestos exposure — have a higher survival rate when treated with a combination of two cancer drugs, a large multicenter study finds. view more (2007-02-09)
New research group offers hope to asbestosis sufferers
The Asbestos Research Group, offering hope to sufferers of asbestos-related diseases, was launched at The Wesley Research Institute today. view more (2008-06-11)
Study shows how carbon nanotubes can affect lining of the lungs
Carbon nanotubes are being considered for use in everything from sports equipment to medical applications, but a great deal remains unknown about whether these materials cause respiratory or other health problems. view more (2009-10-26)
NCI-Penn Collaboration Finds Targeted Immune Cells Shrink Tumors in Mice
Researchers have generated altered immune cells that are able to shrink, and in some cases eradicate, large tumors in mice. view more (2009-02-11)
DKK-3 and WIF-1: Proteins related to liver cancer development?
Liver cancer is one of the most fatal human malignancies and the third most frequent cause of tumor-related death, about half a million people globally each year. view more (2009-06-15)
New strategy in tumor treatment
A new strategy proposed by researchers at Dartmouth Medical School and Amtek, Hanover, NH may treat tumors that do not respond to conventional treatment. view more (2009-07-20)
Mayo researchers discover mechanism of cell type-specific signaling in tumor development
Mayo Clinic researchers have discovered the mechanisms behind two key checkpoints in cell growth and development - factors that may ultimately allow investigators to benchmark progression of tumor cells or stop them from further development. The findings appear in the current online issue of Developmental Cell. view more (2009-04-08)
Clinical trial confirms novel EGFR antibody targets tumors but not normal tissues
The Ludwig Institute for Cancer Research (LICR) and Life Science Pharmaceuticals (LSP) today announced the results of the first clinical trial of monoclonal antibody (mAb) 806, which demonstrate that 806 specifically targets epidermal growth factor receptor (EGFR) on a wide range of tumor types but has no uptake by normal tissues. view more (2006-06-06)
'Signature' of chromosome instability predicts cancer outcomes
Microscopic examination of tumor specimens cannot always predict a cancer's aggressiveness, leading to increased interest in molecular approaches to diagnosis. view more (2006-08-21)
Frog molecule could provide drug treatment for brain tumours
Known as Amphinase, the molecule recognises the sugary coating found on a tumour cell and binds to its surface before invading the cell and inactivating the RNA it contains, causing the tumour to die. view more (2007-06-27)
|
|
|
|
Sort By:
Page Views | Date |
|
